Abstract:Well-known theories of aging suggest that a certain metabolic defect negatively affects vital activity of the cell, be it oxidative stress, the accumulation of lesions in DNA, the exhaustion of telomeres, or distorted epigenetic processes. The theory of aging considered in the review postulates that an accumulation of progerin on the inner side of the nuclear envelope underlies the above defects. Progerin is a defective precursor of the lamin A nuclear matrix protein in which the C-terminal cysteine, which is removed normally, is retained and modified with a hydrophobic oligoisoprene chain. Progerin molecules attach with their hydrophobic processes to the inner membrane of the nuclear envelope, pushing away the adjacent fibrils of the nuclear matrix and the chromatin periphery. This changes the morphology and shape of the nucleus and alters the properties of the nuclear envelope and pore complexes embedded in it. As progerin accumulates in the nucleus, structural distortions increase in the nucleus, further distorting the nuclear-cytoplasmic transport of macromolecules and leading to the above defects in cell metabolism. This leads to increasing cell death and aging of the body over time. This mechanism of aging has been identified in patients with Hutchinson-Gilford progeria syndrome (HGPS). Mass progerin production in HGPS is caused by the point mutation c.1824C→T in exon 11 of the LMNA gene, which codes for lamins A and C. The mutation stimulates non-standard splicing of the primary transcript during the formation of the lamin A precursor mRNA, thus causing progerin production. Children with progeria who have received the mutation from one of their parents age rapidly and die before 15 years of age. Approaches to progeria treatment are aimed at preventing the formation of progerin or destroying the progerin that has already accumulated. In the latter case, a promising strategy is to use rapamycin or its analogs and other substances and techniques that activate autophagy to purify the cell from progerin. Although in much smaller amounts, progerin is found in progeria-free people and may therefore play a role in natural aging. A maximum age that a person can reach is possible to estimate by taking account of the role that progerin plays in telomere shortening. Encouraging preliminary results achieved in purifying cells from progerin provide a means to develop an optimal procedure for periodic purification of the human body from progerin in order to reduce the rate of aging.

Heterochromatin loss as a determinant of progerin‐induced DNA damage in Hutchinson–Gilford Progeria

Progerin Can Induce DNA Damage in the Absence of Global Changes in Replication or Cell Proliferation

Progerin impairs vascular smooth muscle cell growth via the DNA damage response pathway

Progerin and Telomere Dysfunction Collaborate to Trigger Cellular Senescence in Normal Human Fibroblasts

Towards delineating the chain of events that cause premature senescence in the accelerated aging syndrome Hutchinson-Gilford progeria (HGPS)

Correlated Alterations in Genome Organization, Histone Methylation, and DNA–lamin A/C Interactions in Hutchinson-Gilford Progeria Syndrome

Molecular insights into the premature aging disease progeria

[Progerin and Its Role in Accelerated and Natural Aging]

Mechanisms Controlling the Smooth Muscle Cell Death in Progeria Via Down-Regulation of Poly(Adp-Ribose) Polymerase 1

Mechanisms of Genome Instability in Hutchinson-Gilford Progeria

A Lamin A Protein Isoform Overexpressed in Hutchinson–Gilford Progeria Syndrome Interferes with Mitosis in Progeria and Normal Cells

Progerin Expression Induces Inflammation, Oxidative Stress and Senescence in Human Coronary Endothelial Cells

Nuclear envelope budding inhibition slows down progerin-induced aging process

The Accumulation of Progerin Underlies the Loss of Aortic Smooth Muscle Cells in Hutchinson-Gilford Progeria Syndrome

Progerin modulates the IGF-1R/Akt signaling involved in aging

A Cell-Intrinsic Interferon-like Response Links Replication Stress to Cellular Aging Caused by Progerin

Progerin Induces Cell Cycle Arrest by Targeting CDK4 in HEK293T

Cell autonomous and systemic factors in progeria development

The Pathogenic Mechanisms and Therapeutic Strategies of Hutchinson-Gilford Progeria Syndrome

DNA damage responses caused by Zmpste24 deficiency and lamin A mutation in premature ageing

Vascular senescence in progeria: role of endothelial dysfunction